The Journal of Organic Chemistry
Note
(140 μL, 146 mg, 1.40 mmol). The product was isolated as a yellow
solid (164 mg, 68%): mp 65−70 °C; IR (film) 3420, 2939, 2863, 1469,
(125 MHz, CDCl3) δ 141.8, 137.6, 133.4, 132.9, 128.1, 127.8, 127.7,
127.6, 126.4, 126.1, 125.8, 125.2, 124.6, 121.9, 119.7, 119.3, 118.2,
109.5, 70.1, 32.6; HRMS (EI, TOF) exact mass calcd for C20H17NONa
[M + Na]+, 310.1202; found, 310.1190; exact mass calcd for C20H15N
[M − OH]+, 270.1277; found, 270.1268.
1
1371, 1330, 1241, 1194, 1059, 1033, 801, 740, 702 cm−1; H NMR
(500 MHz, CD2Cl2) δ 7.61 (dt, J = 8.0, 1.0 Hz, 1H), 7.58−7.53 (m,
2H), 7.45−7.39 (m, 2H), 7.38−7.32 (m, 2H), 7.27 (ddd, J = 8.2, 7.0,
1.1 Hz, 1H), 7.11 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 6.91 (s, 1H), 6.17 (s,
1H), 3.76 (s, 3H), 2.44 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ
144.2, 137.5, 128.2, 127.3, 127.2, 126.4, 126.3, 121.8, 120.0, 119.6,
119.2, 118.4, 109.4, 70.1, 32.6; HRMS (EI, TOF) exact mass calcd for
C16H15NONa [M + Na]+, 260.1046; found, 260.1043; exact mass
calcd for C16H14N [M − OH]+, 220.1121; found, 220.1124.
Furan-2-yl(1-methyl-1H-indol-3-yl)methanol (2g). The title
compound12 was prepared according to General Procedure A, using
N-methylindole (128 μL, 135 mg, 1.03 mmol) and 2-furanaldehyde
(128 μL, 134 mg, 1.40 mmol). The product was isolated as a dark red
oil (165 mg (corrected to account for residual diethyl ether), 71%): IR
(film) 3386, 3052, 2967, 2932, 2874, 1551, 1474, 1329, 1191, 1063,
1
(1-Methyl-1H-indol-3-yl)(4-nitrophenyl)methanol (2c). The
title compound12 was prepared according to General Procedure A,
using N-methylindole (128 μL, 135 mg 1.03 mmol) and
4-nitrobenzaldehyde (211 mg, 1.40 mmol), except that a different
amount of i-Pr2NEt was used (292 μL, 217 mg 1.68 mmol). The
product was isolated as a pale brown solid (206 mg, 71%): mp 123−
127 °C; IR (film) 3524, 310, 3043, 2928, 1593, 1507, 1331, 1042, 805,
1009, 993, 784, 733 cm−1; H NMR (500 MHz, CD2Cl2) δ 7.71 (dt,
J = 8.0, 1.0 Hz, 1H), 7.52 (dd, J = 1.8, 0.9 Hz, 1H), 7.42 (dt, J = 8.3,
0.9 Hz, 1H), 7.36 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.22 (ddd, J = 7.9,
7.0, 1.1 Hz, 1H), 7.13 (s, 1H), 6.48 (dd, J = 3.2, 1.9 Hz, 1H), 6.39 (dt,
J = 3.2, 0.8 Hz, 1H), 6.17 (s, 1H), 3.77 (s, 3H), 3.01 (bs, 1H); 13C
NMR (125 MHz, CDCl3) δ 156.7, 142.0, 137.4, 127.5, 126.3, 121.9,
119.7, 119.3, 115.2, 110.3, 109.5, 106.7, 64.2, 32.6.; HRMS (EI, TOF)
exact mass calcd for C14H13NO2Na [M + Na]+, 250.0839; found,
250.0844; exact mass calcd for C14H12NO [M − OH]+, 210.0913;
found, 210.0908.
(1H-Indol-3-yl)(thiophen-2-yl)methanol (2h). The title com-
pound12 was prepared according to General Procedure A, using
N-methylindole (128 μL, 135 mg, 1.03 mmol) and 2-thiophenecarbox-
aldehyde (131 μL, 157 mg, 1.40 mmol). The product was isolated as a
pale brown solid (210 mg, 84%): IR (film) 3360, 3047, 2923, 2872,
1609, 1549, 1473, 1423, 1329, 1239, 1155, 1131, 1063, 1024, 978, 853,
764, 739, 701 cm−1; 1H NMR (500 MHz, CD2Cl2) δ 7.61 (dt, J = 8.0,
0.9 Hz, 1H), 7.38 (dt, J = 8.3, 0.9 Hz, 1H), 7.32 (dd, J = 5.0, 1.3 Hz,
1H), 7.27 (ddd, J = 8.2, 7.1, 1.1 Hz, 1H), 7.14−7.10 (m, 2H), 7.07 (dt,
J = 3.5, 1.1 Hz, 1H), 7.02 (dd, J = 5.1, 3.5 Hz, 1H), 6.40 (s, 1H), 3.79
(s, 3H), 2.57 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 148.8, 137.5,
127.2, 126.6, 126.0, 124.6, 124.3, 121.9, 119.6, 119.3, 117.6, 109.5,
66.6, 32.7; HRMS (EI, TOF) exact mass calcd for C14H13NOSNa
[M + Na]+, 266.0610; found, 266.0614; exact mass calcd for C14H13NS
[M − OH]+, 226.0685; found, 226.0678.
(E)-1-(1-Methyl-1H-indol-3-yl)-3-phenylprop-2-en-1-ol (2i).
The title compound12 was prepared according to General Procedure
A, using N-methylindole (128 μL, 135 mg, 1.03 mmol) and trans-
cinnamaldehyde (176 μL, 185 mg, 1.40 mmol). The product was
isolated as an orange-brown oil (172 mg (yield corrected for presence of
residual diethyl ether), 63%): IR (film) 3364, 3050, 3021, 2926, 2863,
1548, 1473, 1447, 1328, 1242, 1154, 1112, 1066, 1012, 962, 737, 692
cm−1; 1H NMR (500 MHz, CD2Cl2) δ 7.83 (dt, J = 8.0, 1.0 Hz, 1H),
7.55−7.47 (m, 2H), 7.44−7.36 (m, 3H), 7.35−7.28 (m, 2H), 7.19
(ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 7.13 (s, 1H), 6.85 (d, J = 16.0, 1H),
6.69 (dd, J = 15.9, 6.1 Hz, 1H), 5.74 (d, J = 6.1 Hz, 1H), 3.79 (s, 3H),
2.33 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 137.5, 137.1, 131.9,
129.6, 128.6, 127.5, 126.8, 126.5, 126.3, 121.8, 119.7, 119.2, 116.9,
109.5, 68.7, 32.6; HRMS (EI, TOF) exact mass calcd for C18H16NO
[M − H]+, 262.1226; found, 262.1218 (weak peak observed only at
130 °C); exact mass calcd for C18H16N [M − OH]+, 246.1277; found,
246.1274.
(1-Benzyl-1H-indol-3-yl)(phenyl)methanol (3a). The title
compound5 was prepared according to General Procedure A, using
N-benzylindole (206 mg, 1.00 mmol) and benzaldehyde (142 μL,
149 mg, 1.40 mmol). The product was isolated as a pale yellow oil
(235 mg, 75%): IR (film) 3343, 1636, 1550, 1452, 1332, 1264, 1170,
1032, 990, 731, 695 cm−1; 1H NMR (500 MHz, CD2Cl2) δ 7.66 (d, J =
8.0 Hz, 1H), 7.60 (d, J = 7.6 Hz, 2H), 7.55−7.32 (m, 7H), 7.32−7.18
(m, 3H), 7.14 (t, J = 7.5 Hz, 1H), 7.07 (s, 1H), 6.21 (s, 1H), 5.31 (s,
2H), 2.58 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 144.1, 137.7,
137.1, 128.7, 128.3, 127.6, 127.3, 126.8, 126.8, 126.8, 126.6, 126.5,
122.1, 119.9, 119.5, 119.1, 110.0, 70.3, 50.1; HRMS (EI, TOF)
exact mass calcd for C22H19NONa [M + Na]+, 336.1359; found,
336.1357.
1
741, 718 cm−1; H NMR (500 MHz, CD2Cl2) δ 8.25−8.19 (m, 2H),
7.76−7.71 (m, 2H), 7.55 (dt, J = 8.0, 1.0 Hz, 1H), 7.36 (dt, J = 8.3,
0.9 Hz, 1H), 7.26 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H), 7.10 (ddd, J = 8.0,
7.0, 1.0 Hz, 1H), 6.94 (s, 1H), 6.26 (s, 1H), 3.78 (s, 3H), 2.50 (bs,
1H); 13C NMR (125 MHz, CDCl3) δ 151.4, 147.1, 137.5, 127.7,
127.0, 125.8, 123.3, 122.1, 119.5, 119.3, 117.0, 109.6, 69.2, 32.7;
HRMS (EI, TOF) exact mass calcd for C16H13N2O3 [M − H]+,
281.0921 (weak peak observed only at 130 °C); found, 281.0927;
exact mass calcd for C16H13N2O2 [M − OH]+, 265.0972; found,
265.0960.
(4-Fluorophenyl)(1-methyl-1H-indol-3-yl)methanol (2d). The
title compound12 was prepared according to General Procedure A,
using N-methylindole (128 μL, 135 mg 1.03 mmol) and
4-fluorobenzaldehyde (150 μL, 174 mg, 1.40 mmol). The product
was isolated as an off-white solid (183 mg, 79%): mp 87−92 °C; IR
(film) 3339, 3054, 2921, 1594, 1506, 1466, 1218, 1154, 979, 817,
1
740 cm−1; H NMR (500 MHz, CD2Cl2) δ 7.56 (dt, J = 8.1, 1.1 Hz,
1H), 7.55−7.48 (m, 2H), 7.36 (d, J = 8.3 Hz, 1H), 7.26 (ddd, J = 8.2,
6.9, 1.2 Hz, 1H), 7.14−7.05 (m, 3H), 6.90 (s, 1H), 6.15 (s, 1H), 3.77
(s, 3H), 2.40 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 162.0 (d, JF
244.2 = Hz), 140.0 (d, JF 3.0 = Hz), 137.5, 128.1 (d, JF = 8.0 Hz),
127.3, 126.1, 121.9, 119.5, 119.2, 118.2, 114.9 (d, JF = 21.4 Hz), 109.4,
69.5, 32.6; HRMS (EI, TOF) exact mass calcd for C16H14NOFNa
[M + Na]+, 278.0952; found, 278.0954; exact mass calcd for
C16H13NF [M − OH]+, 238.1027; found, 238.1037.
(4-Bromophenyl)(1-methyl-1H-indol-3-yl)methanol (2e). The
title compound12 was prepared according to General Procedure A,
using N-methylindole (128 μL, 135 mg 1.03 mmol) and
4-bromobenzaldehyde (259 mg, 1.40 mmol). The product was
isolated as an off-white solid (254 mg, 78%): mp 90−92 °C; IR
(film) 3360, 3047, 2936, 1558, 1479, 1337, 1235, 1068, 1011, 811, 741
1
cm−1; H NMR (500 MHz, CD2Cl2) δ 7.59 (dt, J = 8.0, 1.0 Hz, 1H),
7.57−7.51 (m, 2H), 7.45−7.40 (m, 2H), 7.37 (dt, J = 8.3, 0.9 Hz, 1H),
7.29 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.13 (ddd, J = 7.9, 7.0, 1.1 Hz,
1H), 6.87 (s, 1H), 6.09 (s, 1H), 3.75 (s, 3H), 2.65 (bs, 1H); 13C NMR
(125 MHz, CDCl3) δ 143.3, 137.5, 131.2, 128.2, 127.5, 126.1, 122.0,
120.8, 119.5, 119.3, 117.8, 109.5, 69.4, 32.6; HRMS (EI, TOF) exact
mass calcd for C16H13NOBr [M − H]+, 314.0175, 316.0154; found,
314.0163, 316.0158 (weak peaks observed only at 130 °C); exact mass
calcd for C16H13NBr [M − OH]+, 298.0226, 300.0207; found,
298.0212, 300.0195.
(1-Methyl-1H-indol-3-yl)(naphthalen-2-yl)methanol (2f). The
title compound12 was prepared according to General Procedure A,
using N-methylindole (128 μL, 135 mg 1.03 mmol) and
2-naphthaldehyde (219 mg, 1.40 mmol). The product was isolated
as brown solid (227 mg, 77%): mp 54−57 °C; IR (film) 3364, 3048,
1
1473, 1424, 1329, 1240, 1155, 1028, 996, 818, 738 cm−1; H NMR
(500 MHz, CD2Cl2) δ 8.12 (bs, 1H), 7.95 (ddd, J = 6.8, 5.3, 2.7 Hz,
2H), 7.90 (d, J = 8.5 Hz, 1H), 7.69 (dt, J = 8.0, 1.0 Hz, 1H), 7.63 (dd,
J = 8.5, 1.8 Hz, 1H), 7.62−7.56 (m, 2H), 7.39 (dt, J = 8.3, 1.0 Hz, 1H),
7.32 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.16 (ddd, J = 8.0, 7.0, 1.1 Hz,
1H), 6.90 (s, 1H), 6.33 (s, 1H), 3.71 (s, 3H), 2.90 (bs, 1H); 13C NMR
(1-Allyl-1H-indol-3-yl)(phenyl)methanol (3b). The title com-
pound12 was prepared according to General Procedure A, using
N-allylindole (160 mg, 1.02 mmol) and benzaldehyde (145 μL,
152 mg, 1.43 mmol). The product was isolated as a yellow oil
D
J. Org. Chem. XXXX, XXX, XXX−XXX